Extensive functional analyses have demonstrated that the pituitary homeodomain transcription factor Pitx1 plays a critical role in specifying hindlimb morphology in vertebrates. However, much less is known regarding the target genes and cis-regulatory elements through which Pitx1 acts. Earlier studies suggested that the hindlimb transcription factors Tbx4, HoxC10, and HoxC11 might be transcriptional targets of Pitx1, but definitive evidence for direct regulatory interactions has been lacking. Using ChIP-Seq on embryonic mouse hindlimbs, we have pinpointed the genome-wide location of Pitx1 binding sites during mouse hindlimb development and identified potential gene targets for Pitx1. We determined that Pitx1 binding is significantly enriched near genes involved in limb morphogenesis, including Tbx4, HoxC10, and HoxC11. Notably, Pitx1 is bound to the previously identified HLEA and HLEB hindlimb enhancers of the Tbx4 gene and to a newly identified Tbx2 hindlimb enhancer. Moreover, Pitx1 binding is significantly enriched on hindlimb relative to forelimb-specific cis-regulatory features that are differentially marked by H3K27ac. However, our analysis revealed that Pitx1 also strongly associates with many functionally verified limb enhancers that exhibit similar levels of activity in the embryonic mesenchyme of forelimbs and hindlimbs. We speculate that Pitx1 influences hindlimb morphology both through the activation of hindlimb-specific enhancers as well as through the hindlimb-specific modulation of enhancers that are active in both sets of limbs.
Introduction
The hindlimbs and forelimbs of mice exhibit substantial differences in the relative size, shape and position of bones, muscles, and tendons. Despite these differences in morphology, the majority of limb patterning genes display highly similar patterns of expression in embryonic forelimbs and hindlimbs and are therefore not the primary drivers that specify forelimb or hindlimb-specific morphologies (Duboc and Logan, 2011a) . In fact, relatively little is known regarding the developmental mechanisms that determine limb-type morphology. Hindlimbspecific defects are observed in mouse knockouts of genes that encode the Pitx1, Tbx4, Islet1, and HoxC10 transcription factors, all four of which are predominantly or exclusively expressed in the hindlimb rather than the forelimb of developing mouse embryos (Lanctôt et al., 1999; Szeto et al., 1999; Naiche and Papaioannou, 2003; Hostikka et al., 2009; Kawakami et al., 2011) .
However, to date only Pitx1 has been definitively shown to specify hindlimb-type morphology.
Both loss and gain of function experiments demonstrate a role for Pitx1 in directing the development of hindlimb-specific morphology. The hindlimbs of Pitx1 knockout mice are reduced in size and exhibit a loss of hindlimb-specific features (Lanctôt et al., 1999; Szeto et al., 1999) . For instance, the ilium and the patella do not form, and the relative size, position, and shape of hindlimb bones take on more forelimb-like characteristics. Further evidence of a role for Pitx1 in specifying hindlimb-type morphology comes from ectopic expression experiments. Ectopic expression of Pitx1 in the developing forelimb of mouse or chick embryos is sufficient to induce the forelimbs to adopt a more hindlimb-like morphology (Logan and Tabin, 1999; Delaurier et al., 2006) . The ectopic expression of Pitx1 in embryonic forelimbs is also sufficient to induce the expression of other hindlimb transcription factors, including Tbx4, HoxC10, and HoxC11.
Despite the clear evidence that the Pitx1 transcription factor promotes the formation of hindlimb-type morphology, our understanding of how Pitx1 regulates hindlimb morphology is limited. One potential regulatory target of Pitx1 is the Tbx4 gene. Not only can ectopic Pitx1 induce Tbx4 expression in the embryonic forelimb, but Pitx1 knockout embryos also show reduced Tbx4 expression in the developing hindlimb (Lanctôt et al., 1999; Szeto et al., 1999; Delaurier et al., 2006) . Recent work has demonstrated that restoring Tbx4 expression via a Tbx4 transgene can rescue the ilium loss and hindlimb size reduction observed in Pitx1 knockout mice, suggesting that Tbx4 may be an important target of Pitx1 function (Ouimette et al., 2010; Duboc and Logan, 2011b) . Although it is not currently known whether Pitx1 directly activates Tbx4 expression, highly conserved putative Pitx1 binding sites have been identified in the HLEA and HLEB hindlimb enhancers of Tbx4 (Menke et al., 2008) . Regardless of whether Tbx4 is a direct target of Pitx1, it is clear that many hindlimb features that are lost in Pitx1 null mice, including formation of the kneecap, are not rescued by restoring expression of Tbx4. Therefore, it is evident that Pitx1 cannot mediate its effects solely through the up-regulation of Tbx4, and other transcriptional targets of Pitx1 must confer additional aspects of hindlimb morphology.
Here we investigate the in vivo binding sites of Pitx1 in the developing mouse hindlimb to better understand how Pitx1 regulates hindlimb formation. We perform a global analysis of Pitx1-bound regions via chromatin immunoprecipitation (ChIP) and high-throughput sequencing to determine candidate transcriptional targets. We then investigate the function of specific Pitx1 bound regions that are located in proximity to the Tbx2 and Tbx4 genes. Finally, we examine whether Pitx1 associates with known limb enhancers and establish whether Pitx1 is enriched on hindlimb-specific cis-regulatory elements.
Materials and methods

Chromatin immunoprecipitation
Timed matings were performed with outbred ICR mice (Harlan Laboratories) and embryonic hindlimb buds were collected at E11.5. After cross-linking in 1% formaldehyde in PBS for 30 min, hindlimb buds were rinsed and treated with trypsin for 5 min to generate a single cell suspension. Samples were then sheared by sonication to generate a chromatin size range of 200-600 bp. PureProteome TM Protein G Magnetic Beads (Millipore) were preincubated with Pitx1 antibody (Santa Cruz Biotechnology, sc-18922) before incubating overnight with 400 mg of chromatin.
After washing, immune complexes were eluted from the beads, and protein-DNA crosslinks were reversed by incubating at 65 1C overnight. After treatment with RNase followed by proteinase K, samples were purified with the GeneJET TM PCR Purification Kit (Fermentas). Two independent biological replicates were used to generate two Illumina ChIP-Seq and two control libraries. All ChIP and input chromatin control libraries were produced using the Illumina ChIP-Seq DNA Sample Prep Kit (IP-102-1001) as directed by the manufacturer. Single-end libraries were sequenced on an Illumina GA IIx, producing 36 bp reads (replicate 1), or a HiSeq 2000, producing 50 bp reads (replicate 2), at the HudsonAlpha Institute for Biotechnology.
Quantitative PCR was used to evaluate the relative abundance of HLEA and HLEB in input and Pitx1-ChIP DNA. qPCR assays were performed in triplicate using Maxima TM SYBR Green ROX mix (Fermentas) on an ABI7500 (Applied Biosystems). An unconserved intergenic region upstream of HLEA that lacks matches to known Pitx1 binding motifs was used as a control for normalization. The 2 À DDt method was used for calculating enrichments for each target in ChIP DNA relative to input. The primers used in qPCR were as follows: HLEA-F: 5 0 -GAAATGGCGACCCTTGTCTG-3 0 ; HLEA-R: 5 0 -TCG-AGCTGCAGCTGCAACTC-3 0 ; HLEB-F: 5 0 CTTCTGATTCGATCCACATG-3 0 ; HLEB-R: 5 0 -CTGCTTTAGCATTTTCTGTG-3 0 ; Tbx4control-F: 5 0 -GATGG-TGGCTGATCCTAATG-3 0 ; Tbx4control-R: 5 0 -ACGGATAGGATGTGAAG-GAG-3 0 .
Peak calling and data analysis
Sequencing read quality was evaluated using FastQC (version 0.5.1, http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/). A low quality read filter was then applied in which no reads with more than six bases with a minimum Phred quality score of twenty were retained. Sequencing reads from the ChIP and input control libraries were aligned to the mouse genome (mm9) using Bowtie v0.12.8 (Langmead et al., 2009) with parameters specified to report the best alignment allowing no more than three mismatches within either the first twenty bases (replicate 1) or 28 bases (replicate 2) on the high-quality end of the read and excluding reads that aligned to more than one location in the genome (-best -l 20(28) -n 3 -m 1). Pitx1 peaks were identified using MACS v1.4.2 with default parameters except for the effective genome size set for mouse ( À g mm). Subpeaks from the MACS output were called using PeakSplitter (Salmon-Divon et al., 2010) . Peaks with a false discovery rate (FDR) greater than 5% and a fold enrichment less than three as reported by MACS were discarded. Peaks were then sorted by p-value and categorized into top 1000, top 5000, or all peaks for further analysis. These top subsets are based on the observation that overall MACS peak quality is most effectively evaluated by ranking by reported p-value (Wilbanks and Facciotti, 2010) . For wiggle plots, sequences were scaled based on the number of sequence tags per ten million reads. Peaks were annotated to genes and transcription start sites (TSS) using CEAS v1.0.2 (Shin et al., 2009) with an annotation table built from UCSC known genes and the input control wiggle file produced by MACS. De novo binding motifs were determined using MEME v4.8.1 (Bailey et al., 2009 ) with non-default parameters ( À maxsize 250,000 À mod zoops À nmotifs 10 À minw 5 Àmaxw 20 Àrevcomp) on sequences within750 bp of the summits of the top 1000 peaks based on MACS p-value. The parameters for the MEME analysis were chosen based on the recommendations of the algorithm's authors to balance sensitivity with the execution time of the analysis for large datasets. De novo binding motifs were matched to the JASPAR (Sandelin et al., 2004) and UniPROBE databases (Newburger and Bulyk, 2009 ) using TOMTOM (Gupta et al., 2007) . Peaks were associated with Gene Ontology (GO) terms (Ashburner et al., 2000) and Mouse Genome Informatics (MGI) phenotypes (Eppig et al., 2012) using the Genomic Regions Enrichment of Annotation Tool (GREAT) (Mclean et al., 2010) with the whole genome as background. Significance was evaluated using the reported region-based binomial test. To examine the evolutionary conservation of Pitx1 binding regions, peak overlap was compared to regions of conservation between mouse and human as identified by the ECR Browser (Ovcharenko et al., 2004) . Additional annotation and analysis was performed using BED-Tools v2.16.2 (Quinlan and Hall, 2010) and the BSGenome, GenomicFeatures, rtracklayer, and ChIPpeakAnno packages in R (http://www.bioconductor.org). Pitx1 ChIP-Seq data has been deposited in the Gene Expression Omnibus (GEO Accession Number GSE41591).
Previously published datasets of H3K27ac ChIP-Seq reads from mouse E11.5 forelimb and hindlimb tissues (Cotney et al., 2012) were downloaded from the Gene Expression Omnibus (GEO Accession Numbers GSM875384, GSM875385, GSM875386, and GSM875387). These paired-end reads were aligned with Bowtie using the same parameters as the Pitx1 data. Insert size between the paired-end reads was estimated from the data. This distance was then used to specify the shift size in MACS in lieu of building a shifting model ( À nomodel À shiftsize¼113). These settings allow MACS to effectively identify the broad peaks characteristic of histone marks (Feng et al., 2011) . Two strategies for identifying enriched peaks were used; the standard method in which the input library for a tissue was used as the control, and an alternative method in which the ChIP sample of one tissue was used as the control for the other and vice versa.
Transgenic mice
Pronuclear injection into FVB or C57BL6/CBA F2 embryos was performed to generate transient transgenic F0 mice (Stanford Transgenic Research Facility, Xenogen Biosciences, and Cyagen Biosciences). Prior to microinjection, BAC and plasmid DNAs were purified as described (DiLeone et al., 2000) . Microinjected embryos were collected at E11.5 or E12.5 and stained with Xgal as described (DiLeone et al., 1998) . All mouse work was reviewed by the Stanford University School of Medicine or the University of Georgia IACUC and was performed under an approved Animal Use Protocol.
Tbx2 BAC modifications
Tbx2 mouse BACs RP24-209K13, RP24-376P4, and RP24-84E15 were modified by insertion of an IRES-bGeo into the 3 0 UTR of the Tbx2 gene through the use of a bacterial recombineering system (Lee et al., 2001) . Briefly, 5 0 and 3 0 homology arms from the Tbx2 3 0 UTR were PCR amplified and cloned into pIPTGfTet to produce a Tbx2 targeting cassette (Chandler et al., 2007) . Successfully targeted BAC clones had an IRES-bGeo and an FRT-flanked tetracycline resistance gene (TetR) inserted 38 bp downstream of the Tbx2 stop codon. Transient expression of FLPe recombinase was used to remove the FRT-flanked TetR selection cassette. Correctly targeted BAC clones were identified via PCR and were verified by sequencing the BAC insertion site.
Hsp68 LacZ transgenes
Regions to be tested for enhancer activity were PCR amplified using primers containing NotI restriction sites and were cloned into the NotI site of p5 0 -Not-HspLacZ (DiLeone et al., 1998) . In cases where multiple tandem copies were desired, products were amplified with primers containing XbaI and SpeI sites, cloned into a modified pBS KSþ plasmid with two NotI sites flanking an XbaI site, excised with NotI, and cloned into p5 0 -Not-HspLacZ.
Results and discussion
Pitx1 binding is enriched near gene promoters
A small number of potential transcriptional targets of Pitx1 have been identified through genetic gain and loss of function experiments, but whether Pitx1 directly regulates these genes remains unknown (Lanctôt et al., 1999; Logan and Tabin, 1999; Szeto et al., 1999; Delaurier et al., 2006) . Therefore, we performed high-throughput sequencing of DNA fragments isolated via Pitx1 ChIP to reveal Pitx1 binding sites located around these potential regulatory targets and across the mouse genome. Using a highly specific Pitx1 antibody ( Fig. S1 ), we performed two independent ChIP experiments on chromatin isolated from E11.5 mouse hindlimbs. For replicate 1, a total of 36.2 million and 35.2 million single-end 36 bp reads were generated for the ChIP-Seq and input control libraries, respectively. After quality filtering, 24.9 million (71.3%) ChIP reads and 23.6 million (69.5%) input control reads aligned uniquely to the mouse genome. These uniquely aligned reads were further processed by MACS for redundancy, leading to 19.4 million treatment and 16.4 million control reads used in peak calling. For replicate 1, MACS identified a total of 14,753 peaks, 14,734 of which were retained after filtering for further analysis. For replicate 2, single-end sequencing generated 60.3 million 50 bp reads from the ChIP sample and 55.7 million reads from the input control sample. After quality filtering, 29.1 million (48.3%) ChIP reads and 29.8 million (53.5%) input control reads aligned uniquely. Of these, 28.7 million ChIP reads and 29.4 million input control reads were used for peak calling. For replicate 2, MACS identified a total of 25,027 peaks and 25,006 were retained after filtering based on FDR and fold enrichment.
To combine the results of the two biological replicates, we focused further analysis on the intersection of the two peak sets identified by MACS, our assumption being that ChIP peaks shared by both replicates would represent the most robust signal from the total data ( Fig. S2 ). This intersection generated a list of 10,625 significant peaks. The genome-wide distribution of Pitx1 peak locations suggests that Pitx1 binding is enriched within 250 kb of annotated transcriptional start sites (TSS) (Fig. 1A ). Further analysis of regions within 10 kb of a TSS demonstrated that Pitx1 peaks are significantly enriched in these regions, and highly enriched ( 44 fold) in potential promoter regions within the first 1000 bp upstream of TSS ( Fig. 1B) .
Like other bicoid-related homeodomain transcription factors, Pitx1 has been shown to bind to the DNA sequence TAATCC and related motifs (Lamonerie et al., 1996; Berger et al., 2008) . We determined whether this motif or other unrelated motifs are associated with Pitx1 binding in embryonic mouse hindlimbs by performing a de novo motif analysis with MEME to detect sequences that are enriched750 bp from the summit of the top 1000 Pitx1 ChIP-Seq peaks. The most enriched motif closely matches the in vitro defined Pitx1 binding motif (Fig. 1C ). An examination of the distribution of this motif among the top 10,625 peaks demonstrated that it was dramatically enriched at the summits of Pitx1 peaks (Figs. 1D and S3). In all, 95.8% of Pitx1 peaks contain a match to this motif with a minimum score threshold of 90%. Several other over-represented motifs were also found in association with Pitx1 ChIP-seq peaks, and may represent binding sites for other transcription factors that collaborate with Pitx1 to regulate gene expression ( Fig. S3 ).
Pitx1 binding highlights functionally important subdomains of HLEA
Tbx4 was first identified as a possible regulatory target of Pitx1 based on gain and loss of function experiments performed in chick and mouse more than a decade ago (Lanctôt et al., 1999; Logan and Tabin, 1999; Szeto et al., 1999; Delaurier et al., 2006) . More recently, we identified putative Pitx1 binding sites within two distinct hindlimb enhancers, HLEA and HLEB, which direct the hindlimb specific expression of Tbx4 (Menke et al., 2008) . These two enhancers are each capable of driving reporter gene expression in the hindlimb field prior to hindlimb bud outgrowth and continue to drive expression in the hindlimb late into embryogenesis ( Fig. 2A  and B ; (Menke et al., 2008) ). In order to determine whether Pitx1 associates with either HLEA or HLEB in vivo, we assessed the relative enrichment of HLEA and HLEB after Pitx1 ChIP by quantitative PCR and found that Pitx1 associates with both enhancers (Fig. 2C ). However, the enrichment observed for HLEA was substantially greater than that for HLEB.
We next investigated the functional importance of Pitx1 bound regions of the HLEA element of Tbx4 using our high-resolution ChIP-Seq data and DNA sequence conservation as our starting point. A VISTA alignment (Mayor et al., 2000) of mouse HLEA against the orthologous human sequence identified three distinct regions of conservation across HLEA's span (Fig. 3A) . These three regions are well-conserved in all mammalian genomes that we have examined (30 placental mammals, 2 marsupials, and a monotreme). Of the three regions, however, only the third exhibits conservation beyond mammals with clear sequence conservation to birds and crocodilians (data not shown). The three regions of conservation correspond to three distinct ChIP-Seq subpeaks within a larger HLEA Pitx1 ChIP-Seq peak (Fig. 3B ). While there are 8 sites in mouse HLEA that match known Pitx1 binding motifs, only two of these sites lie directly under prominent Pitx1 summits, suggesting that only a subset of the potential Pitx1 binding sites are bound by Pitx1 in vivo. Since our Pitx1 ChIP-Seq analysis indicated that Pitx1 ChIP signal is greater over the first two conserved regions of HLEA than the third conserved region, we tested the functional importance of these three sub-domains (R1, R2, and R3) for enhancer activity in vivo ( Fig. 3C and K, Table 1, and Fig. S4 ). We deleted R3 from the original HLEA-Hsp68LacZ transgene (Fig. 3C , transgene R1þR2) and found that this transgene drives levels of LacZ expression comparable to the full length HLEA (Fig. 3D and E) . Embryos carrying the HLEA or R1þR2 transgene both display strong staining in the proximal and central regions of the hindlimbs with reproducible, but much lower, levels of activity in the forelimb. In contrast, deletion of R1 results in a complete or nearly complete loss of enhancer activity, and removal of R2 dramatically reduces enhancer activity ( Fig. 3F and G) . Thus, Pitx1 ChIP-Seq signal overlaps functionally important regions (R1 and R2) of HLEA. The R3 domain, which shows less Pitx1 ChIP-Seq signal, appears to be of little or no importance for generating limb enhancer activity at E11.5 in the context of the Hsp68LacZ transgenes that we tested.
HLEA
Our deletion analysis demonstrates that R1 is the most significant region of HLEA for conferring hindlimb enhancer activity at E11.5. We therefore tested the ability of R1 to drive enhancer activity in the absence of both R2 and R3. Production of R1 transgenic embryos established that this region is sufficient to drive modest levels of hindlimb expression ( Fig. 3I ). Comparison of the R1 transgene against the R1þR2 and R1þR3 transgenes indicates that R2 acts to boost the enhancer activity of R1, while R3 has little or no impact on R1 enhancer activity (Fig. 3E , G, and I). As demonstrated previously, mutation of a highly conserved Pitx1 motif, located directly underneath the Pitx1 ChIP-Seq summit of R2, strongly diminished the ability of R2 to stimulate R1 enhancer activity, suggesting that Pitx1 binding is important for robust activation of this enhancer ( Fig. 3E and H; (Menke et al., 2008) ).
While R2 acts jointly with R1 to increase enhancer activity, R2 alone has little or no effect despite the fact that our ChIP-Seq analysis indicates that both regions are bound by Pitx1 ( Fig. 3B and F). To explore functional differences between R1 and R2, we created a transgene construct that contained four tandem copies of R1 in front the Hsp68LacZ cassette. This allowed us to determine whether multiple copies of R1 could increase enhancer activity and functionally substitute for the presence of R2. Including these multiple copies of R1 markedly increased enhancer activity (Fig. 3J ). However, the hindlimb specificity of R1 was lost as increased enhancer activity occurred in both the forelimb and the hindlimb. Unlike R1, four tandem copies of either R2 or R3 produced no detectable limb expression ( Fig. 3K and data not shown). Taken together, our results are consistent with R1 functioning to produce the basic pattern of hindlimb enhancer activity and R2 acting to strengthen this activity.
Pitx1 binding highlights the location of a Tbx2 hindlimb enhancer
In order to further investigate the relationship between Pitx1 binding sites and Tbx4 regulation, we examined our ChIP-Seq data across the Tbx4 locus. In agreement with our Pitx1 ChIP qPCR experiments, our ChIP-Seq data revealed a peak at HLEA, and a small, but significant, peak at HLEB ( Fig. 4A and B ). In addition, we detected strong peaks (in top 1000 category and fold enrichment greater than 10) just downstream of Tbx4 and in a distant upstream region located within an intron of the Bcas3 gene (Fig. 4B) . These additional peaks are located in well-conserved non-coding regions and represent potential cis-regulatory elements for Tbx4 or its neighboring genes, Bcas3 and Tbx2.
We tested the strong Pitx1 ChIP-Seq peak located just 3 0 of the Tbx4 locus for enhancer activity (Fig. 4B) . The underlying sequence associated with this Pitx1 peak is present in Tbx4 BAC transgenes capable of driving hindlimb expression, but this small sub-region had not been tested previously for enhancer activity (Menke et al., 2008) . To test this region specifically, we cloned 6.9 kb of sequence encompassing this Pitx1 peak and flanking conserved sequences and inserted it in front of the Hsp68LacZ cassette. We found that, unlike HLEA and HLEB, this region is not sufficient to drive hindlimb enhancer activity in E11.5 transgenic embryos (data not shown).
We decided next to explore the regulatory landscape around the Pitx1 ChIP-Seq peaks that are located within a Bcas3 intron (Fig. 4B) . The strongest of these intronic peaks is located over 360 kb away from the promoter region of Bcas3 and is in much closer proximity to the promoters of Tbx2 and Tbx4 (117 kb and 170 kb, respectively). Additionally, since Bcas3 does not exhibit substantial expression in the limb buds at E11.5 and previous regulatory analyses of Tbx4 BAC transgenes indicated that this region is not required for robust Tbx4 hindlimb expression, we hypothesized that Pitx1 binding events in this Bcas3 intron might instead be associated with the regulation of Tbx2 (Siva and Inamdar, 2006; Menke et al., 2008) . The Tbx2 gene is expressed along the anterior and posterior margins of the forelimbs and hindlimbs (Chapman et al., 1996) . Thus, this raises the intriguing possibility that Pitx1 might modulate the hindlimb expression of Tbx2, a limb patterning gene that is not hindlimb specific.
We evaluated the ability of three overlapping Tbx2 mouse BACs to drive limb expression. Each of these BACs contained the entire Tbx2 open reading frame with the ends of the BACs staggered across the locus to test the regulatory importance of different flanking regions (Fig. 4C ). An IRES-bGeo reporter was inserted into the 3 0 UTR of Tbx2 in each BAC clone via recombineering, and transient transgenic mouse embryos were generated and stained with X-gal to detect b-galactosidase activity. All three BACs drove common regions of Tbx2 expression in domains where the native Tbx2 gene is expressed, including the dorsal eye and 6 0/6 (0%) 0/6 (0%) 1/6 (17%) 5/6 (83%) 0/6 (0%) 0/6 (0%) 1/6 (17%) 5/6 (83%) R3, 4x 10 0/10 (0%) 0/10 (0%) 2/10 (20%) 8/10 (80%) 0/10 (0%) 0/10 (0%) 1/10 (10%) 9/10 (90%) nasal region ( Fig. 4D and F ; (Chapman et al., 1996) ). In contrast, only the most proximal BAC, RP24-209K13, was capable of driving limb expression in a Tbx2-like pattern with strong expression observed in the posterior portion of both forelimbs and hindlimbs (Fig. 4D) . Tbx2-like limb expression was never observed in the forelimbs or hindlimbs of transgenic embryos carrying the medial or distal BACs ( Fig. 4E and F; 0 out of 5 and 0 out of 6 transient transgenic embryos, respectively). However, Tbx4-like hindlimb expression was sometimes observed with both the medial and distal BAC transgenes ( Fig. S5 and Table S1 ). This hindlimbrestricted expression was likely a result of the presence of the native HLEA and HLEB Tbx4 enhancers, which are contained within the medial and distal BACs. We hypothesize that in the context of a concatenated BAC transgene insertion, these Tbx4 hindlimb enhancers may, in some instances, be able to interact with the promoter of Tbx2 and stimulate hindlimb-specific expression. The Tbx2 BAC scan implicated a 59 kb candidate limb enhancer region that includes the strongest of the Bcas3 intronic Pitx1 peaks (Fig. 4) . We designed five different Hsp68LacZ transgenes from this region that together cover 498% of the sequence in this interval that is conserved between the human and mouse genomes (Fig. 4C) . When tested in vivo, we found that two of the five transgenes clearly exhibit limb enhancer activity in a Tbx2like pattern ( Fig. 4G and I , Table S2 ). Remarkably, the subregion that overlaps the Pitx1 peak reproducibly acts as a hindlimb enhancer with posteriorly restricted expression ( Fig. 4H) . Notably, an adjacent subregion that lacks significant Pitx1 peaks drives posterior limb expression in both forelimbs and hindlimbs (Fig. 4I) . Thus, the 59 kb limb interval contains at least two putative Tbx2 limb enhancers: one characterized by Pitx1 binding and a high level of hindlimb specificity and a second which functions in both forelimbs and hindlimbs and lacks detectable Pitx1 binding. Our results suggest that Tbx2, a limb patterning gene that has similar expression domains in both sets of limbs, has at least partially partitioned hindlimb enhancer activity into a specialized cis-regulatory domain.
Pitx1 preferentially binds to hindlimb cis-regulatory elements
As a hindlimb-restricted transcription factor, Pitx1 could potentially regulate hindlimb gene expression patterns in a number of different ways. For instance, Pitx1 could influence target gene expression by interacting with hindlimb-specific enhancer elements. A second possibility is that Pitx1 could act in the hindlimb to repress the activity of forelimb-specific enhancers, resulting in forelimb/hindlimb expression differences. Alternatively, enhancer elements that are activated in both sets of limbs could be bound by Pitx1 in the hindlimb, resulting in a hindlimb-specific modulation of enhancer activity. These possible mechanisms of Pitx1 action are not mutually exclusive. Consistent with the first scenario, the Pitx1 ChIP-Seq peaks around the Tbx2/Tbx4 locus strongly correlate with the location of cis-regulatory elements with hindlimb-specific enhancer activity ( Fig. 2A and B, Fig. 4A C and H) . Specifically, both of the two known Tbx4 hindlimb enhancers overlap Pitx1 peaks, as does the putative Tbx2 hindlimb enhancer. In contrast, other enhancers in the region, including an intronic Tbx4 lung enhancer and the putative Tbx2 enhancer that drives expression in the forelimbs and hindlimbs, do not overlap Pitx1 peaks ( Fig. 4 and (Menke et al., 2008) ). Moreover, when we examined the genomic region around HoxC10 and HoxC11, two genes from the HoxC cluster that exhibit hindlimb-restricted expression, we found a significant Pitx1 peak in the intergenic interval between these two genes (Fig. 5 ). This peak falls within a 10 kb region that has been shown to contain regulatory sequences sufficient to drive hindlimbrestricted expression in transgenic mouse embryos (Papenbrock et al., 2000) .
To examine the relationship between limb-type specificity of cis-regulatory elements and Pitx1 binding sites more comprehensively, we took advantage of recently published H3K27ac ChIP-Seq data sets generated separately from E11.5 forelimbs and hindlimbs (Cotney et al., 2012) . The histone H3K27ac modification has been shown to mark active enhancers and promoters, and ChIP-Seq against this histone mark is an effective means to identify cis-regulatory elements that are active in a particular cell type or tissue (Creyghton et al., 2010; Ernst et al., 2011; Zentner et al., 2011) . Cotney et al. (2012) demonstrated that the majority of H3K27ac peaks are shared between embryonic forelimbs and hindlimbs and are not limb-type specific, indicating that many of the same cis-regulatory elements are active in both sets of limbs. We examined the overlap of Pitx1 peaks with the location of H3K27ac marks that are shared between forelimbs and hindlimbs, or H3K27ac marks which are uniquely called as significant in only the forelimbs or only the hindlimbs. To ensure consistency between Pitx1 and H3K27ac peak-calling, we reanalyzed the Cotney et al. H3K27ac ChIP-seq data using MACs v1.4.2 ( Fig. S6 ; see materials and methods). We found that Pitx1 peaks overlap a greater proportion of hindlimb-specific elements than forelimbspecific elements ( Fig. 6A; 19% vs. 7.2%, Fisher's exact test, p¼3.44 Â 10 À 59 ).
Our initial comparison of Pitx1 peaks against those H3K27ac marks that are uniquely found in only one limb type or the other did not include cis-regulatory elements that are marked by H3K27ac in both limb-types but which are marked more intensely in either the forelimbs or the hindlimbs. Previous work has demonstrated that the strength of H3K27ac marks correlate with gene transcription, with stronger H3K27ac signals associated with greater levels of gene expression (Cotney et al., 2012) . Consequently, H3K27ac marks that exhibit differences in strength between forelimbs and hindlimbs may highlight enhancers that are preferentially active in one set of limbs over the other. We therefore further analyzed the Cotney et al. H3K27ac data with MACS in order to identify H3K27ac marks that differ significantly in signal strength between the forelimb and hindlimb data sets, but which are not necessarily uniquely present in only one limb-type. Our analysis identified 364 forelimb-biased and 648 hindlimb-biased H3K27ac marked regions. When the Pitx1 peaks were compared Fig. 5 . A Pitx1 ChIP-Seq peak is associated with a HoxC10/11 hindlimb regulatory domain. (A) Conservation plot comparing the mouse and human HoxC gene clusters. Regions of conservation Z100 bp with Z 70% identity between mouse-human and mouse-chicken are highlighted by colored peaks (blue ¼ exons, pink ¼conserved noncoding regions). (B) Pitx1 ChIP-Seq and input control signal. The y-axes of Pitx1 ChIP and input control plots are scaled to indicate the number of sequence tags per ten million reads. A Pitx1 peak located in the intergenic region between HoxC10 and HoxC11 falls within a 10 kb region (orange shading) that has been previously demonstrated to drive hindlimb-specific expression (Papenbrock et al., 2000) . against our stringent set of forelimb-biased and hindlimb-biased H3K27ac marks, we found that Pitx1 overlapped the hindlimbbiased marks $7.5 Â more frequently than forelimb-biased marks (Fig. 6B , Fisher's exact test, p¼1.12 Â 10 À 34 ). Moreover, Pitx1 peaks are over-represented on hindlimb-biased H3K27ac regions and under-represented on forelimb-biased H3K27ac relative to forelimb/ hindlimb common H3K27ac regions (18% of all forelimb/hindlimb common H3K27ac regions overlap with Pitx1 ChIP-seq peaks compared to 37% of hindlimb-biased H3K27ac regions and 5% of forelimb-biased peaks). These results suggest that Pitx1 may influence target gene expression more often by interacting with hindlimb enhancer elements or through the hindlimb-specific modulation of elements that are activated in both sets of limbs, rather than by acting to repress the activity of forelimb-specific enhancers in the hindlimb.
Pitx1 broadly associates with limb enhancers
We observed that approximately 86% of Pitx1 peaks overlap non-coding regions that are well-conserved between mouse and human, suggesting that many of these regions may be functionally important. Since many of these regions are likely to serve as cis-regulatory elements, we investigated whether Pitx1 associates with limb enhancers in the developing hindlimb. For this analysis, we first used the VISTA Enhancer Browser to identify previously characterized enhancers that drive expression specifically in either E11.5 limb buds (n ¼111), the forebrain (n ¼142), the midbrain (n¼ 101), the hindbrain (n ¼74), or the heart (n ¼69) (Visel et al., 2007) . Comparison of these VISTA positive enhancers with Pitx1 ChIP-Seq peaks demonstrated significant enrichment in the limb-specific dataset (Fisher's exact test, p ¼4.02 Â 10 À 40 ). More than 67% of these known limb enhancers overlap a Pitx1 peak, compared to between approximately 1 to 9% of brain or heart specific enhancers (Fig. 7A) . We also tested the overlap between our Pitx1 ChIP-Seq peaks and the locations of putative limb, forebrain, or midbrain enhancers marked by the P300 histone acetyltransferase at E11.5 (Visel et al., 2009 (11%) datasets (Fisher's exact test, p ¼3.32 Â 10 À 222 ; Fig. 6A ). We conclude that Pitx1 associates with many limb cis-regulatory elements during hindlimb bud development.
Pitx1 binding is enriched near limb genes
To investigate genes that may be regulated by Pitx1, we compiled a list of all genes that have a Pitx1 ChIP-Seq summit within 250 kb of their TSS. This list of 4859 Pitx1-associated genes was compared to lists of genes with forelimb-biased (58 genes) or hindlimb-biased expression (127 genes) at E10.5 identified by RNA sequencing (Cotney et al., 2012) . We found no significant difference in the number of Pitx1-associated genes that were in common with either the forelimb or hindlimb-biased expression gene lists (Fisher's exact test, p¼0.5047). Of the genes with forelimb-biased expression, 37.9% have a Pitx1 peak within 250 kb, compared to 32.3% of hindlimbbiased genes. We also compared our Pitx1-associated gene list to datasets of forelimb and hindlimb expressed genes generated from microarray data (Taher et al., 2011) . In this dataset, 23 of 76 (30.3%) forelimb up-regulated genes overlap Pitx1 associated genes, compared to 7 of 11 (63.6%) hindlimb up-regulated genes. There was a higher percentage overlap with hindlimb up-regulated genes and this association was marginally significant (Fisher's exact test, p¼0.0423).
We next investigated whether Pitx1 binding site locations are associated with particular developmental functions, pathways, or gene classes using GREAT (Mclean et al., 2010) . This analysis demonstrated that Pitx1 peaks are strongly associated with genes implicated in limb and skeletal development ( Fig. 7B and C; Fig. S7 ). For instance, 8 of the top 10 enriched terms under GO Biological Process relate to gene groups involved in limb or skeletal development ( Fig. 7B ; p-values ranging from 10 À 59 to 10 À 134 ), and 6 of the top 10 terms under Mouse Phenotype relate specifically to genes required for limb development (Fig. 7C ; p-values ranging from 10 À 76 to 10 À 117 ). Similar term associations are reported for all 10,625 peaks, the top 5000 peaks and the top 1000 peaks based on p-value ( Fig. S7) . Therefore, Pitx1 likely regulates hindlimb morphology by acting upon many different transcriptional targets that are involved in limb patterning and skeletal development.
Conclusions
Our ChIP-Seq analysis of in vivo Pitx1 binding in E11.5 mouse hindlimbs has helped to illuminate its role in the transcriptional regulation of previously identified putative Pitx1 target genes. Specifically, we have established that Tbx4 is, in fact, directly regulated by Pitx1, and we have demonstrated that Pitx1 associated regions highlight functionally important subdomains of the HLEA element of Tbx4. A number of interesting potential targets have also been identified that warrant further investigation. For instance, the discrete HoxC10/11 binding site points to a role for Pitx1 in the regulation of these posterior HoxC cluster genes. This is consistent with gain of function studies that have demonstrated that ectopic expression of Pitx1 in the embryonic mouse forelimb can induce HoxC10 expression and ectopic expression in embryonic chick forelimbs can induce the expression of HoxC10 and HoxC11 (Logan and Tabin, 1999; Delaurier et al., 2006) . Additionally, our analysis of Pitx1 binding sites has led to our identification of a putative Tbx2 hindlimb enhancer. Further analyses will be needed to investigate the relative importance of the different Pitx1 binding sites found within these hindlimb regulatory elements.
Although we identified Pitx1 binding sites in the vicinity of genes with hindlimb-biased gene expression, including Tbx4, HoxC10, and HoxC11, in our global analysis Pitx1 ChIP-Seq peaks did not display clear enrichment near genes that exhibit expression levels that are greater in hindlimbs than forelimbs. This could be explained if Pitx1 has a relatively modest influence on the expression of many of its target genes, since genes with subtle forelimb/hindlimb expression differences are largely excluded from published forelimb and hindlimb gene lists, which focus on genes with large forelimb/hindlimb expression differences (Taher et al., 2011; Cotney et al., 2012) . Alternatively, there is some evidence that Pitx1 can act as an activator or repressor depending on its context (Island et al., 2002) . In this scenario, Pitx1 binding sites could act to reduce or increase the expression of target genes in the hindlimb. A third possibility is that only a small fraction of Pitx1 peaks are biologically relevant and the influence of this subset of peaks on hindlimb gene expression is obscured by binding sites that have little impact on gene transcription. Finally, it is possible that Pitx1 may exert stronger influences on hindlimb expression at earlier developmental stages. ChIP-Seq analyses at additional stages of development and expression analyses of wild-type and Pitx1 knockout mice will be critical in determining which Pitx1 binding sites exert the most significant influence on target gene expression during formation of the hindlimb.
In contrast to the absence of significant enrichment of Pitx1 binding near genes with hindlimb-biased expression, Pitx1 binding was strongly enriched on putative cis-regulatory elements that are marked by H3K27ac more intensely in the hindlimb than the forelimb. These elements represent intriguing candidate regulatory targets for Pitx1, and the influence of Pitx1 on the activity of these elements requires further investigation. Our identification of a Pitx1bound hindlimb enhancer for Tbx2, a gene that exhibits similar expression patterns in the forelimb and hindlimb, is consistent with the hypothesis that Pitx1 promotes hindlimb morphology by modulating the hindlimb expression of important limb patterning genes. In a broader context, across the genome it is apparent that Pitx1 is associating with a large number of limb cis-regulatory elements. Even if Pitx1 only modulates the expression of a fraction of these, there are likely many regulatory targets beyond Tbx4 and HoxC10/11. The large number of limb genes with neighboring Pitx1 ChIP-Seq peaks suggests that Pitx1 influences hindlimb morphology broadly and does not just act through a handful of target genes.
